by Team Small News | Apr 9, 2025 | Aurobindo Pharma, Pharma, Sun Pharma, Zydus
The US government, under President Donald Trump, has announced plans to impose new tariffs on pharmaceutical imports, which could significantly impact India, the top supplier of generic drugs to the US. The move aims to push pharmaceutical manufacturing back to the...
by Team Small News | Apr 9, 2025 | Pharma, Sun Pharma
Indian pharmaceutical company Sun Pharmaceutical Industries has launched Fexuclue, a novel potassium-competitive acid blocker (PCAB) for the treatment of erosive esophagitis in adults. The medication, manufactured under an agreement with South Korean biopharmaceutical...
by Team Small News | Apr 1, 2025 | Aurobindo Pharma, Divi's Laboratories, Pharma, Sun Pharma, Torrent Pharma, Zydus
Citibank has analyzed the potential impact of US tariffs on Indian pharmaceutical companies and has assigned a low probability to such an event. The brokerage firm simulated a 10% tariff scenario and found that companies with a high exposure to US generics, such as...
by Team Small News | Mar 31, 2025 | Pharma, Sun Pharma
Sun Pharma Advanced Research Company (SPARC), a subsidiary of Sun Pharmaceutical Industries, has submitted an Investigational New Drug (IND) application to the United States Food and Drug Administration (USFDA) for its investigational product, SBO-154. SBO-154 is an...
by Team Small News | Mar 19, 2025 | Pharma, Sun Pharma
The New Jersey Economic Development Authority (NJEDA) has approved several initiatives to support the state’s economic growth, including tax credits for Sun Pharmaceutical Industries Inc.’s plan to open a new U.S. headquarters in Princeton, creating 220...
by Team Small News | Mar 14, 2025 | Pharma, Sun Pharma
The New Jersey Economic Development Authority (NJEDA) has approved tax credits for Sun Pharmaceutical Industries Inc. (Sun Pharma) to open a new US headquarters in Princeton, creating 220 new jobs and retaining hundreds of existing ones. This is a significant win for...